Status:
UNKNOWN
Pharmacogenetics for Pain Management in Joint Replacement Patients
Lead Sponsor:
Anderson Orthopaedic Research Institute
Conditions:
Arthroplasty Complications
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the ability to use pharmacogenetic testing in a joint replacement practice to prescribe the most effective pain medicine for a specific patient.
Eligibility Criteria
Inclusion
- Primary total hip or total knee arthroplasty cases
Exclusion
- History of narcotic dependence
Key Trial Info
Start Date :
December 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03772535
Start Date
December 3 2018
End Date
December 1 2021
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anderson Orthopaedic Research Institute
Alexandria, Virginia, United States, 22307